{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:57:40Z","timestamp":1792519060224,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023673","name":"Deanship of Scientific Research, Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002713","name":"Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","award":["IMSIU-DDRSP2501"],"award-info":[{"award-number":["IMSIU-DDRSP2501"]}],"id":[{"id":"10.13039\/501100002713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178129","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T06:33:01Z","timestamp":1757140381000},"page":"178129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Targeting the Skp2\u2013Cks1 protein\u2013protein interaction: structures, assays, and preclinical inhibitors"],"prefix":"10.1016","volume":"1006","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-9564","authenticated-orcid":false,"given":"Emadeldin M.","family":"Kamel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally Mostafa","family":"Khadrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris F.","family":"Aba Alkhayl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al Mokhtar","family":"Lamsabhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178129_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110940","article-title":"A systematic review on understanding the mechanistic pathways and clinical aspects of natural CDK inhibitors on cancer progression.: unlocking cellular and biochemical mechanisms","volume":"393","author":"Asghar","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2025.178129_bib2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/sj.onc.1209861","article-title":"Mutant B-RAF signaling and cyclin D1 regulate Cks1\/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells","volume":"26","author":"Bhatt","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2025.178129_bib3","series-title":"The Role of SKP1 Glycosylation in SCF Assembly and the Characterization of the Interaction of an F-Box Protein and Its Binding Partner","author":"Boland","year":"2022"},{"key":"10.1016\/j.ejphar.2025.178129_bib4","series-title":"Applications, and Uptake Studies","article-title":"Macrocyclization approaches towards stabilization of secondary and tertiary protein motifs: synthetic studies","author":"Brown","year":"2025"},{"key":"10.1016\/j.ejphar.2025.178129_bib5","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1053\/j.gastro.2009.08.005","article-title":"SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis","volume":"137","author":"Calvisi","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.178129_bib6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrm1471","article-title":"The SCF ubiquitin ligase: insights into a molecular machine","volume":"5","author":"Cardozo","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.178129_bib7","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/j.yexcr.2007.04.027","article-title":"Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines","volume":"313","author":"Dohda","year":"2007","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2025.178129_bib8","series-title":"The Potential Therapeutic Benefit of Targeting S-phase kinase-associated Protein 2 (SKP2) in Neuroblastoma","author":"Evans","year":"2015"},{"key":"10.1016\/j.ejphar.2025.178129_bib9","series-title":"Molecular and Clinical Implications of SKP2 Inhibition in Osteosarcoma","author":"Ferrena","year":"2024"},{"key":"10.1016\/j.ejphar.2025.178129_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1538-7445.AM2023-553","article-title":"Abstract 553: SKP2 knockout induces macrophage infiltration in p53\/Rb1 null transgenic mouse models of osteosarcoma and drives gene expression correlated with improved survival in patients","volume":"83","author":"Ferrena","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2025.178129_bib11","article-title":"Comprehensive single cell transcriptomics analysis of murine osteosarcoma uncovers Skp2 function in metastasis, genomic instability and immune activation and reveals additional target pathways","author":"Ferrena","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejphar.2025.178129_bib12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/cells9020460","article-title":"Natural compounds in prostate cancer prevention and treatment: mechanisms of action and molecular targets","volume":"9","author":"Fontana","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.178129_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54917-1","article-title":"Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27","volume":"9","author":"Garc\u00eda-Guti\u00e9rrez","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178129_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2005.09.003","article-title":"Structural basis of the Cks1-Dependent recognition of p27Kip1 by the SCFSkp2 ubiquitin ligase","volume":"20","author":"Hao","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2025.178129_bib15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2741\/4320","article-title":"E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy","volume":"20","author":"Hao","year":"2015","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejphar.2025.178129_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1021\/acschembio.3c00642","article-title":"Exploiting the cullin E3 Ligase adaptor protein SKP1 for targeted protein degradation","volume":"19","author":"Hong","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejphar.2025.178129_bib17","article-title":"Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1","volume":"11","author":"Hu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178129_bib18","doi-asserted-by":"crossref","first-page":"16435","DOI":"10.1021\/acs.jmedchem.4c01283","article-title":"Discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidine derivatives as novel potent S-Phase kinase-associated protein 2 (SKP2) inhibitors for the treatment of cancer","volume":"67","author":"Hu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178129_bib19","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1158\/1078-0432.CCR-15-0254","article-title":"NEDD8 inhibition overcomes CKS1B-Induced drug resistance by upregulation of p21 in multiple myeloma","volume":"21","author":"Huang","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.178129_bib20","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0076-6879(05)99047-2","article-title":"High\u2010Throughput screening for inhibitors of the Cks1\u2013Skp2 interaction","author":"Huang","year":"2005"},{"key":"10.1016\/j.ejphar.2025.178129_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-5793(99)01211-9","article-title":"Identification of a novel Skp2-like mammalian protein containing F-box and leucine-rich repeats","volume":"459","author":"Ilyin","year":"1999","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.ejphar.2025.178129_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12967-016-0823-y","article-title":"Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells","volume":"14","author":"Iskandarani","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2025.178129_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molcel.2004.09.029","article-title":"An Rb-Skp2-p27 pathway Mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant","volume":"16","author":"Ji","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2025.178129_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.12.002","article-title":"Dioscin: a new potential inhibitor of Skp2 for cancer therapy","volume":"51","author":"Jiang","year":"2020","journal-title":"EBioMedicine"},{"issue":"2023","key":"10.1016\/j.ejphar.2025.178129_bib25","article-title":"Small-molecule compounds inhibiting S-phase kinase-associated protein 2: a review","volume":"14","author":"Jing","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178129_bib26","series-title":"Investigating Regulation of Cyclin-dependent Kinases by SCF Ubiquitin Ligases and Pharmacological Kinase Inhibitors","author":"Kelso","year":"2022"},{"key":"10.1016\/j.ejphar.2025.178129_bib27","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4236\/jct.2013.48159","article-title":"Cks1: structure, emerging roles and implications in multiple cancers","volume":"4","author":"Khattar","year":"2013","journal-title":"J. Cancer Ther."},{"key":"10.1016\/j.ejphar.2025.178129_bib28","article-title":"Molecular study of the mechanisms of action of CDK4 and CDK6 inhibitors Etude mol\u00e9culaire des m\u00e9canismes d'action d'inhibiteurs de CDK4 et CDK6","author":"Kim","year":"2021","journal-title":"Universit\u00e9 Paris Cit\u00e9"},{"key":"10.1016\/j.ejphar.2025.178129_bib29","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2174\/0929867323666160510122624","article-title":"Skp2 inhibitors: novel anticancer strategies","volume":"23","author":"Lee","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178129_bib30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/cells11050851","article-title":"Ubiquitination-Proteasome System (UPS) and autophagy two main protein degradation machineries in response to cell stress","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.178129_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114156","article-title":"NAE modulators: a potential therapy for gastric carcinoma","volume":"231","author":"Liang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178129_bib32","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.3390\/ijms21186885","article-title":"Targeting molecular mechanisms underlying treatment efficacy and resistance in Osteosarcoma: a review of Current and future strategies","volume":"21","author":"Lilienthal","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178129_bib33","series-title":"Structural Exploration of Different Binding Pockets Suitable to Affect Protein Kinases CK2\u03b1 and CK2\u03b1\u2019With Peptides and Small Molecules","author":"Lindenblatt","year":"2022"},{"key":"10.1016\/j.ejphar.2025.178129_bib34","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.3390\/ijms21082894","article-title":"The ubiquitin conjugating enzyme: an important ubiquitin transfer platform in ubiquitin-proteasome System","volume":"21","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178129_bib35","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1038\/ncomms4463","article-title":"Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity","volume":"5","author":"Lu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.178129_bib36","series-title":"Cullin-RING Ligases and Protein Neddylation: Biology and Therapeutics","first-page":"111","article-title":"The biology of F-box proteins: the SCF family of E3 ubiquitin ligases","author":"Nguyen","year":"2020"},{"key":"10.1016\/j.ejphar.2025.178129_bib37","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1210\/en.2013-1757","article-title":"Inhibitors of SCF-Skp2\/Cks1 E3 Ligase block Estrogen-Induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer","volume":"154","author":"Pavlides","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2025.178129_bib38","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41375-019-0653-z","article-title":"Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL","volume":"34","author":"Rodriguez","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.ejphar.2025.178129_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-37609-9","article-title":"Cryo-EM structure of SKP1-SKP2-CKS1 in complex with CDK2-cyclin A-p27KIP1","volume":"13","author":"Rowland","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178129_bib40","series-title":"Cullin-RING Ligases and Protein Neddylation: Biology and Therapeutics","first-page":"9","article-title":"Structural biology of CRL ubiquitin ligases","author":"Rusnac","year":"2020"},{"key":"10.1016\/j.ejphar.2025.178129_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.166795","article-title":"Discriminative SKP2 interactions with CDK-Cyclin complexes support a cyclin A-Specific role in p27KIP1 degradation","volume":"433","author":"Salamina","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejphar.2025.178129_bib42","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/s41416-022-01990-5","article-title":"Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4\/6 inhibition in GIST","volume":"127","author":"Schaefer","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2025.178129_bib43","series-title":"Design and Synthesis of small-molecule Inhibitors Targeting the SCFSKP2 E3 Ligase and the MDMX-p53 Interaction for Cancer Therapy","author":"Shouksmith","year":"2015"},{"key":"10.1016\/j.ejphar.2025.178129_bib44","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2174\/1381612828666220601153426","article-title":"Chemotherapeutic activities of dietary phytoestrogens against prostate cancer: from observational to clinical studies","volume":"28","author":"Sohel","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2025.178129_bib45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1097-2765(01)00210-6","article-title":"A CDK-Independent function of Mammalian Cks1: targeting of SCFSkp2 to the CDK inhibitor p27Kip1","volume":"7","author":"Spruck","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2025.178129_bib46","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/14728222.2024.2387604","article-title":"An overview of Skp2: a promising new therapeutic target of psoriasis","volume":"28","author":"Tomar","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2025.178129_bib47","series-title":"Tumour Suppressor Role of S-phase Kinase Associated Protein 1-cullin-F box-S-phase Kinase Associated Protein 2 (Scfskp2)","author":"Vasavan","year":"2015"},{"key":"10.1016\/j.ejphar.2025.178129_bib48","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41388-024-02942-4","article-title":"Targeted inhibition of SCFSKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma","volume":"43","author":"Wang","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2025.178129_bib49","unstructured":"Wei, J., Xu, C., Structural Insight into the SKP1-CUL1-FBXO3-RBX1 complex. Proteins: Struct., Funct., Bioinf. n\/a."},{"issue":"2024","key":"10.1016\/j.ejphar.2025.178129_bib50","article-title":"SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies","volume":"14","author":"William","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2025.178129_bib51","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.chembiol.2012.09.015","article-title":"Specific small molecule inhibitors of Skp2-Mediated p27 degradation","volume":"19","author":"Wu","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejphar.2025.178129_bib52","article-title":"The \u03b2-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor","volume":"8","author":"Xu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.178129_bib53","article-title":"Cks1 N45R Kl blocks Mouse Rb1\/Trp53-deficient prostate cancer development and reveals the p27-dependent Skp2 degradation","author":"Xue","year":"2022","journal-title":"Albert Einstein College of Medicine"},{"key":"10.1016\/j.ejphar.2025.178129_bib54","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s42003-025-07662-3","article-title":"Distinct outcomes from targeted perturbations of the multi-subunit SCFSkp2 E3 ubiquitin ligase in blocking Trp53\/Rb1-null prostate tumorigenesis","volume":"8","author":"Xue","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejphar.2025.178129_bib55","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1538-7445.AM2021-2928","article-title":"Abstract 2928: evaluating Cks1-Skp2 interface as an effective therapeutic target for RB1-deficient metastatic castration-resistant prostate cancer (mCRPC)","volume":"81","author":"Xue","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2025.178129_bib56","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1182\/blood-2006-07-038703","article-title":"CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms","volume":"109","author":"Zhan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2025.178129_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101109","article-title":"USP2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates","volume":"297","author":"Zhang","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178129_bib58","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.1021\/acs.jmedchem.2c01675","article-title":"Discovery of novel 1,3-Diphenylpyrazine derivatives as potent S-Phase kinase-associated protein 2 (Skp2) inhibitors for the treatment of cancer","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178129_bib59","series-title":"RB1 Loss Accelerates Acquired Therapeutic Resistance in EGFR Mutant Lung Adenocarcinoma via Lineage Plasticity","author":"Zhang","year":"2021"},{"key":"10.1016\/j.ejphar.2025.178129_bib60","doi-asserted-by":"crossref","first-page":"154","DOI":"10.37349\/eds.2024.00041","article-title":"Stapled peptides: targeting protein-protein interactions in drug development","volume":"2","author":"Zhang","year":"2024","journal-title":"Exploration of Drug Science"},{"key":"10.1016\/j.ejphar.2025.178129_bib61","article-title":"Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178129_bib62","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1158\/0008-5472.CAN-19-2400","article-title":"Targeted inhibition of the E3 Ligase SCFSkp2\/Cks1 has antitumor activity in RB1-Deficient human and mouse small-cell lung cancer","volume":"80","author":"Zhao","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2025.178129_bib63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/onc.2016.175","article-title":"p27T187A knockin identifies Skp2\/Cks1 pocket inhibitors for advanced prostate cancer","volume":"36","author":"Zhao","year":"2017","journal-title":"Oncogene"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925008830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925008830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:29:39Z","timestamp":1780201779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925008830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":63,"alternative-id":["S0014299925008830"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178129","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the Skp2\u2013Cks1 protein\u2013protein interaction: structures, assays, and preclinical inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178129"}}